Study: Protein patterns help doctors distinguish bladder cancer cases:
This article was originally published in Clinica
Executive Summary
US researchers have identified a pattern of 22 proteins that could help distinguish patients with bladder cancer from individuals with other malignant and non-malignant genitourinary diseases. Their specific protein pattern model allowed them to correctly identify in urine samples between 86% and 100% of 31 patients with urothelial carcinoma, 138 people who had other genitourinary diseases, and 11 healthy individuals. The findings, by a team from the University of Virginia Health Sciences Center, in Charlottesville, appear in the March issue of The Lancet Oncology.
You may also be interested in...
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.